Institutional investors purchased a net $19.9 million shares of BIOS during the quarter ended March 2017 and now own 95.50% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Managed Health Care industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GILDER, GAGNON, HOWE & CO. LLC Bought 8.8 Million shares of BioScrip Inc
ARES MANAGEMENT LLC Bought 7.8 Million shares of BioScrip Inc
GABELLI SECURITIES, INC. Bought 850.00 shares of BioScrip Inc